ESR1 and breast carcinoma: Paakkola et al. [7] reported that ER-low+ breast cancer had a more similar outcome to that of ER− than to ER+ breast cancer in disease-free survival (DFS) and overall survival (OS) and discussed the prognosis based on ER status.